This ADC product is composed of an anti-CD70 antibody (clone h1F6) conjuagated via a vc linker to CC-1065 (rachelmycin) (h1F6-vc-CC-1065). It has demonstrated a response in Advanced/recurrent clear cell renal cell carcinoma or relapsed/refractory B-cell non-Hodgkin's lymphoma treatment by a MOA (Mechanism of Action) of DNA minor groove alkylator.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-H76 | Anti-Human CD70 Recombinant Antibody (Vorsetuzumab) | ELISA, FC, IP, FuncS, IF, Neut, ICC | IgG1 - kappa |
TAB-335LC-S(P) | Human Anti-CD70 Recombinant Antibody; scFv Fragment (TAB-335LC-S(P)) | ELISA | Humanized scFv |
TAB-342LC-S(P) | Human Anti-CD70 Recombinant Antibody; scFv Fragment (TAB-342LC-S(P)) | FC | Humanized scFv |
TAB-343LC-S(P) | Human Anti-CD70 Recombinant Antibody; scFv Fragment (TAB-343LC-S(P)) | FC | Humanized scFv |
TAB-344LC-S(P) | Human Anti-CD70 Recombinant Antibody; scFv Fragment (TAB-344LC-S(P)) | FC | Human scFv |
There are currently no Customer reviews or questions for ADC-073LCT. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.